Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prokidney (PROK) Enterprise Value (2022 - 2025)

Prokidney (PROK) has disclosed Enterprise Value for 4 consecutive years, with $1.2 billion as the latest value for Q3 2025.

  • On a quarterly basis, Enterprise Value fell 6.39% to $1.2 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $1.2 billion, a 6.39% decrease, with the full-year FY2024 number at $1.3 billion, down 9.53% from a year prior.
  • Enterprise Value was $1.2 billion for Q3 2025 at Prokidney, down from $1.3 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of $1.8 billion in Q1 2023 to a low of $1.1 billion in Q3 2022.
  • A 4-year average of $1.3 billion and a median of $1.3 billion in 2024 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: grew 29.05% in 2023, then dropped 24.09% in 2024.
  • Prokidney's Enterprise Value stood at $1.1 billion in 2022, then rose by 29.05% to $1.4 billion in 2023, then dropped by 9.53% to $1.3 billion in 2024, then dropped by 5.12% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for PROK's Enterprise Value are $1.2 billion (Q3 2025), $1.3 billion (Q2 2025), and $1.3 billion (Q1 2025).